SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-23-001484
Filing Date
2023-11-14
Accepted
2023-11-14 06:14:17
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g083836_10q.htm   iXBRL 10-Q 639681
2 EXHIBIT 31.1 g083836_ex31-1.htm EX-31.1 9002
3 EXHIBIT 31.2 g083836_ex31-2.htm EX-31.2 8962
4 EXHIBIT 32.1 g083836_ex32-1.htm EX-32.1 4479
5 EXHIBIT 32.2 g083836_ex32-2.htm EX-32.2 4249
  Complete submission text file 0001753926-23-001484.txt   3791903

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20230930.xsd EX-101.SCH 37807
7 XBRL CALCULATION FILE lipo-20230930_cal.xml EX-101.CAL 44390
8 XBRL DEFINITION FILE lipo-20230930_def.xml EX-101.DEF 110913
9 XBRL LABEL FILE lipo-20230930_lab.xml EX-101.LAB 285009
10 XBRL PRESENTATION FILE lipo-20230930_pre.xml EX-101.PRE 216999
58 EXTRACTED XBRL INSTANCE DOCUMENT g083836_10q_htm.xml XML 471259
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41575 | Film No.: 231401407
SIC: 2834 Pharmaceutical Preparations